The studies make clear that achieving costs below $7 per kg will require higher-density cell cultures, more efficient use of food-grade media, food-grade equipment in facilities, significant but attainable cost reductions in recombinant protein and growth factor production, and more relaxed payback time criteria for capital expenditures, says the Good Food Institute (GFI), which commissioned the studies along with Belgian animal rights advocacy group GAIA.
The two studies - atechno-economic assessment (TEA)and a life cycle assessment (LCA)- model the costs and environmental impacts of a hypothetical commercial-scale cell-cultured meat facility churning out 10,000 metric tons of ground meat a year at a temperature of around 37C (98.6F) in 2030.
The meat in question would be a slurry or paste made out of meat cells, comparable to very finely ground meat, suitable for further formulation into meat-consumer products as opposed to a next-generation more structured, steak-like product, explain the authors at CE Delft, noting that cells from water-based species can be grown at lower temperatures (15-30C), saving some heating costs.
Basic thermodynamics dictate that growing meat from cells in bioreactors instead of living, breathing, animals should be more efficient, as resources are spent on growing only the cells that make up the meat product rather than maintaining the day-to-day activities of an entire animals body, noted GFI senior scientist Elliot Swartz, in an analysis of the studies you can read HERE.
However, there are many known unknowns (and likely some unknown unknowns too) when it comes to producing cell-cultured meat on an industrial scale, added Swartz, noting for example, to our knowledge, the large-volume perfusion bioreactor systems as described in the LCA and TEA do not yet exist.
Future work should therefore be focused on optimizing existing systems or developing new systems that can efficiently expand or differentiate skeletal muscle and adipose tissue or support co-cultures of multiple cell types, he said.
Conceptually, this could require embedding scaffolding structures within a bioreactor or using permeable biomaterials to house encapsulated cells in spheres, sheets, or tubes. Further development of fit-for-purpose perfusion bioreactors for cultivated meat production offers a large whitespace opportunity for new companies.
CE Delft looked at capital costs, maintenance, cleaning, labor, wastewater treatment; heat, electricity, culture medium costs and other inputs such as chemicals, filters, scaffolds, vials and ultrapure water; coupled with cell bank maintenance, small-scale proliferation, large-scale proliferation, differentiation and maturation, and harvesting and food safety measures.
The authors acknowledge that every firm uses a different cell culture medium, a combination of water, amino acids, sugars, salts, vitamins, recombinant proteins and growth factors signaling proteins that encourage cells to proliferate and differentiate, which come with a hefty price tag. For the purposes of this study, it selects albumin, insulin, and transferrin and FGF-2 and TGF-.
Reducing the costs of growth factors [such as FGF-2]has a substantial impact on cultivated meat costs, and limiting the use of recombinant proteins [such as albumin] together with reducing the production price seems even more vital to bring cultivated meat production costs down.
But they added: Prices are falling rapidly already, which is promising for the future.
Maximizing cell density during the proliferation stages will also be key to reducing costs, said CE Delft, which estimates that by 2030, a hypothetical cell-cultured meat facility might be able to compete with some conventional meats on cost, with production costs (as opposed to wholesale or retail prices) as low as $5.66/kg or $2.57 per pound, with hybrid meats combining plant-based and cell-cultured meats providing a near-term opportunity to further reduce costs and improve texture.
The studies did not, however, factor in specialized and automated cultivators for meat production, cell culture media recycling, or improved methods for growth factor production, which could make a significant difference to the economic equation, noted Swartz at the GFI.
The findings should not be taken as unchanging truths or as the absolute lower bounds of costs and environmental impacts of cultivated meat.
For example, he said, perhaps recombinant proteins or growth factors can be produced in less resource-intensive hosts, or manufacturers could work out how to do more with less by engineering more potent or thermostable variants, developing encapsulated or slow-release systems, using conditioned medium from other animal cell lines, relying on high-density cell cultures to become self-sustaining, or by discovering biofunctional equivalents in plants or other organisms.
Serum- and albumin-free medium formulations are commonplace for the culturing of pluripotent stem cells, which increases confidence that albumin may be able to be eliminated entirely from use in cultivated meat manufacturing.
So what about sustainability?
The environmental impact of cell-cultured meat is largely driven by energy use; primarily electricity use during production itself, but also electricity and heat use in upstream production of medium, according to CE Delfts LCA report: We therefore see that electricity use is the most important driver for the environmental single score impact of cultivated meat in a conventional energy scenario.
If renewable energy is used to power cell-cultured meat production, this could reduce global warming impacts by 17%, 52%, and 85-92%; and land use by 63%, 72%, and up to 95% vs conventional chicken, pork, and beef production, respectively, even when compared to an extremely optimistic scenario projecting reduced environmental impacts of conventional animal agriculture, including renewable energy at farm and feed operations, said Swartz at the GFI.
These conclusions are expected to be highly robust, as the study also accounts for uncertainty in cultivated meat production by conservatively assuming high energy use at the facility, which is representative of an upper estimate.
If land currently used for conventional meat production (mostly for feed) iscarefullyrepurposed to rebuild ecosystems and sequester carbon or simply grow more human-edible food, added Swartz, we can significantly offset carbon emissions, and address global food security challenges.
Consistent withprevious studies, said Swartz, cultivated meat is also expected to be less polluting than all forms of conventional meat and use significantly less blue water (found in surface and groundwater reservoirs) than conventional beef production (but about the same as chicken and pork).
It could also bring other positive benefits, including mitigation of antibiotic resistance, foodborne illness, and zoonotic disease risk associated with conventional animal agriculture, restoration of terrestrial and marine habitats, and a decreased rate of biodiversity loss.
The overall environmental score for cell-cultured meat, however, is still higher than plant-based meat, according to CE Delft.
*The 16 companies were: Cultivated meat research institute (Avian), Aleph Farms (cell cultured beef), Avant Meats (cell cultured fish), Mosa Meat (cell cultured beef), Shiok Meats (cell cultured crustaceans), SuperMeat (cell cultured poultry), Wild Type (cell cultured fish), Akron Biotech (recombinant proteins, scaffolds, cell banking systems), Black & Veatch (consulting engineering and design-build services), Buhler (extrusion and feed pre-mix), Cell-trainer Biotech (consulting engineering), Evides (water production and treatment), Merck (cell culture media and other process related products), OSPIN (bioreactors and tissue chambers for cell expansion and differentiation), Richcore (recombinant proteins), and Warner Advisors (consulting engineering).
See the original post here:
When will cell-cultured meat reach price parity with conventional meat? - FoodNavigator-USA.com
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
- Sight Care Reviews - Overpriced or Worth the Hype? SightCare Pills ... - Journal of the San Juan Islands - November 9th, 2023
- 6 Amazing Health Benefits Of Giloy (Tinospora cordifolia) - WION - November 9th, 2023
- The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising... - November 7th, 2023
Recent Comments